Issue 02 of the Klisu homepage — the range, page by page. Formulation, feel, wear time, and who it was made for. Take your time.
Somewhere between ten-step routines and filtered glass skin, the part that keeps skin calm — the barrier — fell out of the conversation. Klisu is a quiet return to it. Formulated in Seoul. Re-tuned for Mumbai humidity, Delhi dry-air, and every climate in between.
Every piece in this index is written to one brief: repair the skin barrier, then get out of the way. No hero molecule on a poster; no ten-step seduction. Just ceramides matched to the skin's own 3:1:1 ratio, madecassoside for the nights, PDRN for the mist, and a mineral SPF that earns its place.
We measured every claim over 28 days in a cohort of sixty-two Indian readers. You'll see the numbers in the science band below, and the quiet letters after. Glow is a side effect. You didn't need another product; you needed the right five. Turn the page.
The index · p. 01 → 05
A weightless ceramide cream. Softens in seconds, sits quietly under SPF and make-up. The first thing we'd hand a tired face.
A deeper repair for evenings. Madecassoside at 2%, panthenol, peptides. Press, don't rub. You wake up calmer.
Water-based semi-tint with Tinosorb S/M hybrid filters. No white cast, no film — a second-skin finish that still feels like nothing.
A mist that acts like a serum. PDRN, peptides, panthenol on a humectant base. Mid-day reset in one pump — keep it on the desk.
For hands that sanitise, type, and carry. Shea and oat β-glucan in a plant-ceramide base. Absorbs in one rub, never greasy.
Readers · Issue 02
"Three weeks in, cheeks stopped tingling after face wash. That was the first sign the barrier was healing."
"ICU shifts wreck skin. Night Reset is the last thing I use each night. By morning my face feels mine again."
"Four-pm in Bengaluru is a different climate. Two pumps of the mist and skin is back. Everyone asks what changed."
"Nine years of melasma. The sunscreen hasn't erased it — it's not growing. That is the first honest win I've had."